Intellectual Property Law and Copyright Laws

As artificial intelligence moves from experimental tools into core business operations, companies face complex questions about ownership, evidence, vendor risk, and cross-border enforcement. The convergence of AI governance, policy, and sovereignty is reshaping how intellectual property rights are created, protected, and enforced across jurisdictions.

The USPTO has announced significant updates to its data access requirements, pilot programs, and trademark examination procedures. New precedential and informative decisions from the Patent Trial and Appeal Board establish important standards for Director discretion in AIA reviews and address inconsistent claim construction positions between Board proceedings and district court litigation.

Samsung Bioepis launches OPUVIZ aflibercept biosimilar in Europe, Amneal and Kashiv challenge Novartis omalizumab patent, EMA recommends two ranibizumab biosimilars, Eli Lilly acquires three vaccine companies...

A Massachusetts federal court granted summary judgment to Alexion Pharmaceuticals, dismissing Amyndas Pharmaceuticals' Chapter 93A unfair competition claim based on alleged misuse of confidential information during partnership negotiations. The decision rigorously enforces causation requirements and clarifies the boundaries between trade secret protection and legitimate competitive activity in pharmaceutical business development.

This quarterly installment examines critical legal challenges facing in-house counsel, from WD-40's trade secret protection strategy and copyright ownership complexities to the emerging risks attorneys face when integrating generative AI into their practice. The series also explores how trademark law intersects with AI-generated deepfakes and why relying on public AI tools for legal guidance may compromise privilege protections.

Nossaman's Intellectual Property and Media Practice Group delivers comprehensive legal services across trademark, copyright, trade secret, and patent matters.

This webinar explores the complex landscape of patent applications for microorganisms and specific strains, examining when biological deposits are necessary and how they impact patent strategy. Attendees will learn practical approaches to drafting applications that support both deposited strain claims and broader microorganism claims, while understanding the scope of protection and potential infringement scenarios.

Mediation outcomes in intellectual property disputes depend on more than just facts and legal arguments. Financial investment, time allocation, mediator expertise, and structural choices all signal the level of seriousness parties bring to the negotiation table...

The State of Colorado has taken a notable step in reshaping how creative businesses can be structured and financed with the introduction of the Colorado Artist Company Act (SB26 133).

As artificial intelligence moves from experimental tools into core business operations, companies face complex questions about ownership, evidence, vendor risk, and cross-border enforcement. The convergence of AI governance, policy, and sovereignty is reshaping how intellectual property rights are created, protected, and enforced across jurisdictions.

Nike's attempt to register a B9 logo for basketball player Bronny James has been rejected due to a conflict with an existing trademark from Black 9 Golf. This case highlights the complexities of trademark registration in the sports and fashion industry, where brand protection and potential conflicts must be carefully navigated.

The USPTO has announced significant updates to its data access requirements, pilot programs, and trademark examination procedures. New precedential and informative decisions from the Patent Trial and Appeal Board establish important standards for Director discretion in AIA reviews and address inconsistent claim construction positions between Board proceedings and district court litigation.